Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients.Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases.The company is a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that makes meaningful medicines and will change the approach in treating diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 23, 2020 | Series A | $700M | 1 | — | — | Detail |
Jan 1, 2019 | Seed | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
ARCH Venture Partners | — | Series A |